- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gestational Diabetes Mellitus in India
Total 515 results
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, China, Japan, Taiwan, India
-
Johnson & Johnson Private LimitedCompleted
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, Taiwan, India
-
PhenomixUnknownType 2 Diabetes MellitusUnited States, Argentina, Canada, India, Mexico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, India, Romania, Spain, Mexico, Turkey, Portugal, Egypt
-
BIOTRONIK Asia Pacific Pte LtdCompletedMyocardial Ischemia | Coronary Artery Disease | Diabetes Mellitus Type 1 or 2China, India, Malaysia, Vietnam, Sri Lanka
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Japan, India, Puerto Rico, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Relatives to/Carers of Patients | Healthcare ProfessionalsSpain, Algeria, China, India, Mexico, Russian Federation, Turkey, Germany, Poland, Japan, Netherlands, Italy, Canada, United Kingdom, Denmark, France, United States
-
AstraZenecaCompleted
-
NovartisCompletedType 2 Diabetes MellitusGermany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom
-
AstraZenecaCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania, Slovakia, Israel, Saudi Arabia, India, Malaysia, Mexico, Russian Federation, Germany, Croatia, Poland, Serbia, Bulgaria, Canada, Slovenia, Sweden, Denmark, Hungary, Argentina, Austria, Finland, Lebanon, Czechia, Netherlands
-
Postgraduate Institute of Medical Education and...CompletedVitamin D Deficiency | PrediabetesIndia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Philippines, China, India
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin DependentUnited States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, China, India
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
-
Nilratan Sircar Medical CollegeUnknownHydatidiform MoleIndia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Colombia, Egypt, Guatemala, India, Iran, Islamic Republic of, Lebanon, Mexico, Russian Federation, South Africa, Tunisia, Turkey, Ukraine, United Arab Emirates
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Korea, Republic of, China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, South Africa, Canada
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Spain, Sweden, India, Mexico, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chile, Puerto Rico
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Malaysia, South Africa, Algeria, Lebanon, United Arab Emirates
-
Indian Council of Medical ResearchCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Serbia, Bulgaria, Australia, Korea, Republic of, Thailand, Turkey, United Arab Emirates, Hungary
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Poland, Spain, India, Argentina, China
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
CymaBay Therapeutics, Inc.Completed
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
Eli Lilly and CompanyCompletedDiabetes Mellitus | Diabetic NeuropathiesUnited States, Spain, Australia, Belgium, Canada, Croatia, Denmark, Estonia, Finland, Germany, Hungary, India, Lithuania, Netherlands, United Kingdom
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
NovartisCompletedType 2 Diabetes Mellitus | Impaired Glucose ToleranceUnited States, Canada, Finland, Australia, Germany, India, Italy
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIndia, Macedonia, The Former Yugoslav Republic of, Russian Federation, Turkey, Croatia, Australia, Philippines
-
CymaBay Therapeutics, Inc.CompletedType 2 DiabetesUnited States, Israel, Argentina, India
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Hungary, Taiwan, Romania, India, South Africa, Philippines, Slovakia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus Type 2Korea, Republic of, Hungary, United States, Mexico, Argentina, India, Poland, Taiwan, Spain
-
Public Health Foundation of IndiaNational Heart, Lung, and Blood Institute (NHLBI); All India Institute of Medical... and other collaboratorsUnknownHypertension | Type 2 Diabetes Mellitus | DyslipidaemiaIndia, Pakistan
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes Mellitus | Hypercholesterolemia | Pre-diabetesUnited States, Colombia, India, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Denmark, Sweden, Malaysia, Poland, Turkey, Finland, Australia, Thailand, Taiwan